Assyro AI

Orange Book product · Brand (NDA)

ZELSUVMI

BERDAZIMER SODIUM

Brand (NDA)NDA 217424RX LNHC

At a glance

Jan 05, 2024

Approved

Brand (NDA)

Application

Not listed

TE code

22

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 05, 2024

    2 yr 6 mo ago

  2. Patent 8282967 expires

    Listed drug substance patent expiration.

    May 30, 2026

    20 d ago

  3. Patent 8956658 expires

    Listed drug substance patent expiration.

    May 30, 2026

    20 d ago

  4. Today

  5. Exclusivity ends · NCE

    New chemical entity exclusivity (5 years)

    Jan 05, 2029

    in 2 yr 7 mo

  6. Patent 10376538 expires

    Listed drug product patent expiration.

    Aug 20, 2030

    in 4 yr 3 mo

  7. Patent 9737561 expires

    Listed method-of-use patent (U-3802) expiration.

    Aug 20, 2030

    in 4 yr 3 mo

  8. Patent 9526738 expires

    Listed drug product patent expiration.

    Sep 03, 2031

    in 5 yr 3 mo

  9. Patent 10265334 expires

    Listed drug product patent expiration.

    Jul 03, 2032

    in 6 yr 2 mo

  10. Patent 9289442 expires

    Listed drug product patent expiration.

    Jul 03, 2032

    in 6 yr 2 mo

  11. Patent 9855211 expires

    Listed drug product patent expiration.

    Feb 27, 2034

    in 7 yr 10 mo

  12. Patent 9855211 expires

    Listed drug product patent expiration.

    Feb 27, 2034

    in 7 yr 10 mo

  13. Patent 11285098 expires

    Listed drug product patent expiration.

    Feb 28, 2034

    in 7 yr 10 mo

  14. Patent 10258564 expires

    Listed method-of-use patent (U-3797) expiration.

    Nov 22, 2034

    in 8 yr 7 mo

  15. Patent 10258564 expires

    Listed method-of-use patent (U-3798) expiration.

    Nov 22, 2034

    in 8 yr 7 mo

  16. Patent 10258564 expires

    Listed method-of-use patent (U-3799) expiration.

    Nov 22, 2034

    in 8 yr 7 mo

  17. Patent 10322081 expires

    Listed method-of-use patent (U-3793) expiration.

    Jul 10, 2035

    in 9 yr 2 mo

  18. Patent 10322081 expires

    Listed method-of-use patent (U-3794) expiration.

    Jul 10, 2035

    in 9 yr 2 mo

  19. Patent 10322081 expires

    Listed method-of-use patent (U-3795) expiration.

    Jul 10, 2035

    in 9 yr 2 mo

  20. Patent 10322081 expires

    Listed method-of-use patent (U-3796) expiration.

    Jul 10, 2035

    in 9 yr 2 mo

  21. Patent 10736839 expires

    Listed method-of-use patent (U-3790) expiration.

    Jul 10, 2035

    in 9 yr 2 mo

  22. Patent 10736839 expires

    Listed method-of-use patent (U-3791) expiration.

    Jul 10, 2035

    in 9 yr 2 mo

  23. Patent 10736839 expires

    Listed method-of-use patent (U-3792) expiration.

    Jul 10, 2035

    in 9 yr 2 mo

  24. Patent 11040006 expires

    Listed drug product patent expiration.

    Jul 10, 2035

    in 9 yr 2 mo

  25. Patent 11723858 expires

    Listed drug product patent expiration.

    Jul 10, 2035

    in 9 yr 2 mo

Pharmaceutical detail

Active ingredient

BERDAZIMER SODIUM

Strength

EQ 10.3% BASE

Dosage form

GEL

Route

TOPICAL

TE code

Not listed

Application

NDA 217424

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (1)

  • NCENew chemical entity exclusivity (5 years)

    Jan 05, 2029

    in 2 yr 7 mo

Listed patents (22)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8282967May 30, 202620 d ago
Substance
8956658May 30, 202620 d ago
Substance
10376538Aug 20, 2030in 4 yr 3 mo
Product
9737561Aug 20, 2030in 4 yr 3 mo
U-3802
9526738Sep 03, 2031in 5 yr 3 mo
Product
10265334Jul 03, 2032in 6 yr 2 mo
Product
9289442Jul 03, 2032in 6 yr 2 mo
ProductU-3803
9855211Feb 27, 2034in 7 yr 10 mo
ProductU-3800
9855211Feb 27, 2034in 7 yr 10 mo
ProductU-3801
11285098Feb 28, 2034in 7 yr 10 mo
Product
10258564Nov 22, 2034in 8 yr 7 mo
U-3797
10258564Nov 22, 2034in 8 yr 7 mo
U-3798
10258564Nov 22, 2034in 8 yr 7 mo
U-3799
10322081Jul 10, 2035in 9 yr 2 mo
U-3793
10322081Jul 10, 2035in 9 yr 2 mo
U-3794
10322081Jul 10, 2035in 9 yr 2 mo
U-3795
10322081Jul 10, 2035in 9 yr 2 mo
U-3796
10736839Jul 10, 2035in 9 yr 2 mo
U-3790
10736839Jul 10, 2035in 9 yr 2 mo
U-3791
10736839Jul 10, 2035in 9 yr 2 mo
U-3792
11040006Jul 10, 2035in 9 yr 2 mo
ProductU-3789
11723858Jul 10, 2035in 9 yr 2 mo
ProductU-3788
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.